Atovaquone and Proguanil HCl (PD-Rx Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Atovaquone and Proguanil HCl drug offered from PD-Rx Pharmaceuticals, Inc.. This Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | PD-Rx Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | atovaquone and proguanil hydrochloride |
| SUBSTANCE NAME: | ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2012-07-27 |
| END MARKETING DATE: | 0000-00-00 |
Atovaquone and Proguanil HCl HUMAN PRESCRIPTION DRUG Details:
| Item Description | Atovaquone and Proguanil HCl from PD-Rx Pharmaceuticals, Inc. |
| LABELER NAME: | PD-Rx Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250; 100(mg/1; mg/1) |
| START MARKETING DATE: | 2012-07-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 43063-522_5bffde46-0267-3933-e053-2a91aa0a10c3 |
| PRODUCT NDC: | 43063-522 |
| APPLICATION NUMBER: | NDA021078 |
Other ATOVAQUONE; PROGUANIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
